Search Within

Irene Y Cheung

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (13)
  3. GSK Faculty (13)
  4. General Oncology Service (13)
  5. Human Oncology and Pathogenesis Program (13)
  6. Neuroblastoma Service (13)

More Groups

People
  1. Nai-Kong Cheung (13)
  2. Katharine Hsu (6)
  3. Shakeel Modak (6)
  4. Brian Kushner (5)
  5. Karen Danis (5)
  6. Bo Dupont (4)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2018 (2)
  4. 2012 (1)
  5. 2011 (1)
  6. 2010 (1)

More Years

Publications
  1. Clinical Cancer Research (3)
  2. Blood (2)
  3. Cancer Research (2)
  4. Journal of Clinical Oncology (2)
  5. Pediatric Blood and Cancer (2)
  6. Nature Genetics (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Society of Clinical Oncology (2)
  3. American Society of Hematology (2)
  4. Wiley Periodicals, Inc (2)
  5. Landes Bioscience (1)
  6. Nature Publishing Group (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clonal evolution during metastatic spread in high-risk neuroblastoma
    Journal Article

    Gundem, G.; Levine, M. F.; Roberts, S. S.; Cheung, I. Y.; Medina-Martínez, J. S.; Feng, Y.; Arango-Ossa, J. E.; Chadoutaud, L.; Rita, M.; Asimomitis, G.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor
    Journal Article

    Cheung, I. Y.; Hsu, K.; Cheung, N. K. V.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma
    Journal Article

    Venstrom, J. M.; Zheng, J.; Noor, N.; Danis, K. E.; Yeh, A. W.; Cheung, I. Y.; Dupont, B.; O'Reilly, R. J.; Cheung, N. K. V.; Hsu, K. C.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Lack of HLA class I ligands for autologous inhibitory KIR is associated with improved survival following autologous stem cell transplant for children with neuroblastoma
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Hasan, R. S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Blood (2008)

    Fulltext@MSK | Save